Oxygen sensing by mitochondria at complex III: The paradox of increased reactive oxygen species during hypoxia

Experimental Physiology

Volumn 91, Issue 5, 2006, Pages 807-819

  Guzy, Robert D ^a   Schumacker, Paul T ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Ward Building 12 191 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; UBIQUINOL CYTOCHROME C REDUCTASE;

ADAPTATION; CELL COMPARTMENTALIZATION; CELL SURVIVAL; CONFERENCE PAPER; EUKARYOTIC CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HIGH ENERGY PHOSPHATE; HYPOXIA; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; OXYGEN SENSING; RESPIRATORY CHAIN; SENSOR; SIGNAL TRANSDUCTION;

EID: 33747596652     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2006.033506     Document Type: Conference Paper

References (88)

1. Agani FH, Pichiule P, Chavez JC & LaManna JC (2000). The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J Biol Chem 275, 35863-35867. (2004).
2. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW et al. (2004). Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279, 38458-38465.
3. Aprelikova O, Wood M, Tackett S, Chandramouli GV & Barrett JC (2006). Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res 66, 5641-5647.
4. Berra E, Benizri E, Ginouves A, Volmat V, Roux D & Pouyssegur J (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J 22, 4082-4090.
5. Bruick RK & McKnight SL (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
6. Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M et al. (2005). Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 1, 409-414.
7. 2 sensor. J Biol Chem 273, 3320-3326.
8. Bunn HF & Poyton RO (1996). Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76, 839-885.
9. Chandel NS, Budinger GRS, Choe SH & Schumacker PT (1997). Cellular respiration during hypoxia: role of cytochrome oxidase as the oxygen sensor in hepatocytes. J Biol Chem 272, 111-112.
10. Chandel N, Budinger GRS, Kemp RA & Schumacker PT (1995). Inhibition of cytochrome-c oxidase activity during prolonged hypoxia. Am J Physiol 268, L918-L925.
11. Chandel NS, Budinger GRS & Schumacker PT (1996). Molecular oxygen modulates cytochrome c oxidase function. J Biol Chem 271, 18672-18677.
12. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC & Schumacker PT (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A 95, 11715-11720.
13. 0) yield insight into physiological mechanisms. FEBS Lett 454, 173-176.
14. Clifton IJ, Hsueh LC, Baldwin JE, Harlos K & Schofield CJ (2001). Structure of proline 3-hydroxylase - evolution of the family of 2-oxoglutarate dependent oxygenases. Eur J Biochem 268, 6625-6636.
15. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC et al. (2000). Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275, 25733-25741.
16. DeHaan C, Habibi-Nazhad B, Yan E, Salloum N, Parliament M & lalunis-Turner J (2004). Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells. Mol Cancer 3, 19.
17. Duranteau J, Chandel NS, Kulisz A, Shao Z & Schumacker PT (1998). Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273, 11619-11624.
18. Ebert BL & Bunn HF (1998). Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol 18, 4089-4096.
19. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
20. Erecinska M & Wilson DF (1982). Regulation of cellular energy metabolism. J Membr Biol 70, 1-14.
21. Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D et al. (2004). JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118, 781-794.
22. Gleadle JM, Ebert BL, Firth JD & Ratcliffe PJ (1995a). Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 268, C1362-C1368.
23. Gleadle JM, Ebert BL & Ratcliffe PJ (1995b). Diphenylene iodonium inhibits the induction of erythropoietin and other mammalian genes by hypoxia. Eur J Biochem 234, 92-99.
24. Goldwasser E, Beru N & Smith D (1989). Erythropoietin: the primary regulator of red cell formation. In Handbook of Experimental Pharmacology, Peptide Growth Factors and Their Regulation, ed. Sporn MB & Roberts AB, pp. 747-770. Springer-Verlag, Berlin, Heidelberg.
25. Graf PCF, Martinez-Yamout M, VanHaerents S, Lilie H, Dyson HJ & Jakob U (2004). Activation of the redox-regulated chaperone Hsp33 by domain unfolding. J Biol Chem 279, 20529-20538.
26. Greijer AE, van der Groep P, Kemming D, Shvarts A, Semenza GL, Meijer GA, van de Wiel MA, Belien JA, van Diest PJ & van der WE (2005). Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206, 291-304.
27. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440-3450.
28. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH et al. (2005). Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122, 337-349.
29. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD et al. (2005). Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1, 401-408.
30. Hirsilae M, Koivunen P, Guenzler V, Kivirikko KI & Myllyharju J (2003). Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278, 30772-30780.
31. 2 in mammalian cells. Proc Natl Acad Sci U S A 96, 6255-6260.
32. Hu CJ, Wang LY, Chodosh LA, Keith B & Simon MC (2003). Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23, 9361-9374.
33. Huang LE, Arany Z, Livingston DM & Bunn HF (1996). Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J Biol Chem 271, 32253-32259.
34. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 95, 7987-7992.
35. Hunte C, Palsdottir H & Trumpower BL (2003). Protonmotive pathways and mechanisms in the cytochrome bc1 complex. FEBS Lett 545, 39-46.
36. Ivan M, Haberberger T, Gervasi DC, Michelson KS, Guenzler V, Kondo K et al. (2002). Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci U S A 99, 13459-13464.
37. 2 sensing. Science 292, 464-468.
38. Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B et al. (1998). Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science 281, 64-71.
39. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12, 149-162.
40. 2-regulated prolyl hydroxylation. Science 292, 468-472.
41. Jakob U, Muse W, Eser M & Bardwell JC (1999). Chaperone activity with a redox switch. Cell 96, 341-352.
42. Jensen PK (1966). Antimycin-insensitive oxidation of succinate and reduced nicotinamide-adenine dinucleotide in electron-tranport particles. Biochim Biophys Acta 122, 157-166.
43. 2 tension. Am J Physiol 271, C1172-C1180.
44. Kaelin WG Jr (2003). The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J Am Soc Nephrol 14, 2703-2711.
45. Kaelin WG Jr (2005). ROS: really involved in oxygen sensing. Cell Metab 1, 357-358.
46. King MP & Attardi G (1989). Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246, 500-503.
47. Land SC, Buck LT & Hochachka PW (1993). Response of protein synthesis to anoxia and recovery in anoxia-tolerant hepatocytes. Am J Physiol 265, R41-R48.
48. Li K, Li Y, Shelton JM, Richardson JA, Spencer E, Chen ZJ et al. (2000). Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 101, 389-399.
49. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA & Simon MC (1997). Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403-407.
50. Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP et al. (2005). Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 1, 393-399.
51. Maxwell PH, Pugh CW & Ratcliffe PJ (1993). Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci U S A 90, 2423-2427.
52. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
53. Mole DR, Maxwell PH, Pugh CW & Ratcliffe PJ (2001). Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. IUBMB Life 52, 43-47.
54. Muller FL, Liu Y & Van Remmen H (2004). Complex III releases superoxide to both sides of the inner mitochondrial membrane. J Biol Chem 279, 49064-49073.
55. Park SK, Dadak AM, Haase VH, Fontana L, Giaccia AJ & Johnson RS (2003). Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Mol Cell Biol 23, 4959-4971.
56. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM & Ratcliffe PJ (1997). Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J Biol Chem 272, 11205-11214.
57. Rana M, de Coo I, Diaz F, Smeets H & Moracs CT (2000). An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann Neurol 48, 774-781.
58. Rumsey WL, Schlosser C, Nuutinen EM, Robiolio M & Wilson DF (1990). Cellular energetics and the oxygen dependence of respiration in cardiac myocytes isolated from adult rat. J Biol Chem 265, 15392-15399.
59. Ryan HE, Lo J & Johnson RS (1998). HIF-1alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17, 3005-3015.
60. Salceda S & Caro J (1997). Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J Biol Chem 272, 22642-22647.
61. Saraste M (1999). Oxidative phosphorylation at the fin de siecle. Science 283, 1488-1493.
62. Schroedl C, McClintock DS, Budinger GRS & Chandel NS (2002). Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 283, L922-L931.
63. Schumacker PT (2005). Hypoxia-inducible factor-1 (HIF-1). Crit Care Med 33, S423-S425.
64. Semenza GL (1999). Perspectives on oxygen sensing. Cell 98, 281-284.
65. Semenza GL (2000). HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88, 1474-1480.
66. Semenza GL, Nejfelt MK, Chi SM & Antonarakis SE (1991). Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci U S A 88, 5680-5684.
67. Semenza GL, Roth PH, Fang H-M & Wang GL (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269, 23757-23763.
68. Semenza GL & Wang GL (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Molec Cell Biol 12, 5447-5454.
69. Sowter HM, Raval R, Moore J, Ratcliffe PJ & Harris AL (2003). Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 63, 6130-6134.
70. Srinivas V, Leshchinsky I, Sang N, King MP, Minchenko A & Caro J (2001). Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J Biol Chem 276, 21995-21998.
71. Sun H & Trumpower BL (2003). Superoxide anion generation by the cytochrome bc1 complex. Arch Biochem Biophys 419, 198-206.
72. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW et al. (2000). The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157, 411-421.
73. Tanimoto K, Makino Y, Pereira T & Poellinger L (2000). Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19, 4298-4309.
74. Trumpower BL (2002). A concerted, alternating sites mechanism of ubiquinol oxidation by the dimeric cytochrome bc1 complex. Biochim Biophys Acta 1555, 166-173.
75. Turrens JF (2003). Mitochondrial formation of reactive oxygen species. J Physiol 552, 335-344.
76. Turrens JF, Alexandre A & Lehninger AL (1985). Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 237, 408-414.
77. Vanden Hoek TL, Becker LB, Shao Z, Li C & Schumacker PT (1998). Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 273, 18092-18098.
78. Vaux EC, Metzen E, Yeates KM & Ratcliffe PJ (2001). Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood 98, 296-302.
79. Wallace DC (2001). Mouse models for mitochondrial disease. Am J Med Genet 106, 71-93.
80. Wang V, Davis DA, Haque M, Huang LE & Yarchoan R (2005). Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res 65, 3299-3306.
81. Wang GL & Semenza GL (1993). General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90, 4304-4308.
82. Wang GL & Semenza GL (1995). Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270, 1230-1237.
83. Waypa GB, Marks JD, Mack MM, Boriboun C, Mungai PT & Schumacker PT (2002). Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res 91, 719-726.
84. Wilson DF, Erecinska M, Drown C & Silver IA (1979). The oxygen dependence of cellular energy metabolism. Arch Biochem Biophys 195, 485-493.
85. Wilson DF, Rumsey WL, Green TJ & Vanderkooi JM (1988). The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration. J Biol Chem 263, 2712-2718.
86. Wykoff CC, Pugh CW, Maxwell PH, Harris AL & Ratcliffe PJ (2000). Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 19, 6297-6305.
87. Wykoff CC, Sotiriou C, Cockman ME, Ratcliffe PJ, Maxwell P et al. (2004). Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene. Br J Cancer 90, 1235-1243.
88. Yu CA, Xia D, Kim H, Deisenhofer J, Zhang L, Kachurin AM & Yu L (1998). Structural basis of functions of the mitochondrial cytochrome bc1 complex. Biochim Biophys Acta 1365, 151-158.